Manalang, Erlinda T.
HRN: 24-46-26 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/24/2024
CEFTRIAXONE 1G (VIAL)
01/24/2024
01/31/2024
IV
1g
Q12H
CAP MR
Waiting Final Action